Cryoport, Inc. provides temperature-controlled supply chain solutions for the Life Sciences, with an emphasis on regenerative medicine. The Company supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The Company's segments include Life Sciences Services and Life Sciences Products. The Company's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.
종목 코드 CYRX
회사 이름Cryoport Inc
상장일Jul 24, 2015
설립일1990
CEOMr. Jerrell Wilson (Jerry) Shelton
직원 수1090
유형Ordinary Share
회계 연도 종료Jul 24
주소112 Westwood Place, Suite 350
도시BRENTWOOD
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호37027
전화19492321900
웹사이트https://www.cryoport.com/
종목 코드 CYRX
상장일Jul 24, 2015
설립일1990
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음